Drug-Related Side Effects and Adverse Reactions
"Drug-Related Side Effects and Adverse Reactions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals.
| Descriptor ID |
D064420
|
| MeSH Number(s) |
C25.100
|
| Concept/Terms |
Drug-Related Side Effects and Adverse Reactions- Drug-Related Side Effects and Adverse Reactions
- Drug Related Side Effects and Adverse Reactions
- Side Effects of Drugs
- Drug Side Effects
- Drug Side Effect
- Effects, Drug Side
- Side Effect, Drug
- Side Effects, Drug
- Adverse Drug Reaction
- Adverse Drug Reactions
- Drug Reaction, Adverse
- Drug Reactions, Adverse
- Reactions, Adverse Drug
- Adverse Drug Event
- Adverse Drug Events
- Drug Event, Adverse
- Drug Events, Adverse
Drug Toxicity- Drug Toxicity
- Toxicity, Drug
- Drug Toxicities
- Toxicities, Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug-Related Side Effects and Adverse Reactions".
Below are MeSH descriptors whose meaning is more specific than "Drug-Related Side Effects and Adverse Reactions".
This graph shows the total number of publications written about "Drug-Related Side Effects and Adverse Reactions" by people in this website by year, and whether "Drug-Related Side Effects and Adverse Reactions" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 1 | 2 |
| 2002 | 2 | 0 | 2 |
| 2003 | 0 | 2 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 2 | 2 |
| 2006 | 0 | 4 | 4 |
| 2007 | 4 | 7 | 11 |
| 2008 | 2 | 4 | 6 |
| 2009 | 4 | 2 | 6 |
| 2010 | 6 | 5 | 11 |
| 2011 | 3 | 4 | 7 |
| 2012 | 1 | 3 | 4 |
| 2013 | 2 | 3 | 5 |
| 2014 | 4 | 1 | 5 |
| 2015 | 3 | 4 | 7 |
| 2016 | 5 | 3 | 8 |
| 2017 | 8 | 3 | 11 |
| 2018 | 5 | 4 | 9 |
| 2019 | 8 | 2 | 10 |
| 2020 | 9 | 2 | 11 |
| 2021 | 11 | 3 | 14 |
| 2022 | 7 | 0 | 7 |
| 2023 | 3 | 1 | 4 |
| 2024 | 3 | 5 | 8 |
| 2025 | 2 | 1 | 3 |
| 2026 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug-Related Side Effects and Adverse Reactions" by people in Profiles.
-
US Risk Evaluation and Mitigation Strategies with Elements to Assure Safe Use: A Longitudinal Analysis of REMS Modifications (2008-2022). Drug Saf. 2026 Jul; 49(7):829-841.
-
Long-Term Safety of Upadacitinib in Patients With Inflammatory Bowel Disease: Integrated Analysis of Phase 2/3 Studies. Clin Gastroenterol Hepatol. 2026 Oct; 24(10):2783-2795.
-
Reducing Medication-Related Harm Through Home-Based Primary Care. J Am Geriatr Soc. 2026 04; 74(4):1218-1220.
-
Publicly Available Clinical Trial Safety Data: Review and a Call for Standardization and Improved Reporting Practices. Pharmaceut Med. 2026 03; 40(2):145-161.
-
Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: A Multicenter Study. Clin Gastroenterol Hepatol. 2025 Nov; 23(12):2281-2291.e4.
-
Targeting molecular pathways to control immune checkpoint inhibitor toxicities. Trends Immunol. 2025 01; 46(1):61-73.
-
Use of Medications With Somnolence Adverse Effects and Somnolence Symptoms Among Older Adults in the U.S. J Aging Health. 2025 Dec; 37(10):721-732.
-
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024. J Natl Compr Canc Netw. 2024 11; 22(9):582-592.
-
Long-term Effectiveness and Safety of Risankizumab in Patients With Crohn's Disease. Clin Gastroenterol Hepatol. 2025 Sep; 23(10):1817-1823.
-
Behavioral Science: Enhancing Our Approach to the Development of Effective Additional Risk Minimization Strategies. Drug Saf. 2024 Aug; 47(8):733-743.